Typicality: | 0.397 |
Saliency: | 0.346 |
to finance | 10 | transitive-object |
to medicines | 3 | transitive-object |
at every stage | 2 | temporal |
measure → promote → access | 18 |
measure → encourage → access | 8 |
negative | neutral | positive |
0.019 | 0.540 | 0.441 |
Raw frequency | 26 |
Normalized frequency | 0.346 |
Modifier score | 0.500 |
Perplexity | 148.132 |